baber/WOPTO huggingface dataset:
Patent EP-3684578-A1 (EP)
Inventor: SCHAAF ULRICH
IPC: B29C45/57
Filed: 2018-08-09
Abstract: The invention relates to a device (10; 10a) for producing components (3, 4) which are at least partially covered with a casting compound and (1) arranged on a carrier element (2), having at least two tool parts (11; 11a, 12) which are arranged so as to be movable relative to one another and which, in a closed position, form a receiving space (55) for receiving the carrier element (2) with the components (3. 4) and the casting compound (1), wherein at least one tool part (11, 11a) is operatively connected to an elastically formed element (30) on the side facing said tool part (11; 11a).
Patent EP-3668590-A1 (EP)
Inventor: HOFMANN BORIS
IPC: H01L23/31
Filed: 2018-08-10
Abstract: In a method for isolating a passivation (10), an isolating wall (30) is arranged along the circumference of at least one opening (15) created in a predetermined way in the passivation (10). A resultant passivation system has an electrically and/or fluid-tightly and gas-tightly isolating wall (30) along the circumference of at least the opening (15) created in a predetermined way in the passivation (10). The isolating wall (30) of a predetermined thickness along a circumference of an opening (15) produced in a predetermined way in a passivation (10) of a medical implant advantageously provides an isolation of the passivation (10) or components of the same with respect to electricity and/or liquid from the opening (15) acting on the passivation (10) or the components of the same.
Patent EP-3668732-A1 (EP)
Inventor: MINISINI ANTOINE
IPC: B60G21/05
Filed: 2018-07-17
Abstract: The invention relates to a motor vehicle rear axle-assembly cross member having a sheet-metal cross member (2) that forms, in a section perpendicular to its length, an open "U" shape and is equipped with a support (14) provided to absorb a force transmitted to this cross member (2), this system being noteworthy in that it has at least two tubular inserts passing through the cross member (2), a spacer (30) fitted in this cross member (2), and fastening screws (28) for fastening the support (14) to the cross member (2), which are fitted in these inserts.
Patent EP-3656085-A1 (EP)
Inventor: SHARIFI KAMRAN
IPC: H04L9/32
Filed: 2018-07-18
Abstract: A device may include one or more sources such as circuit elements and electrical components that function as sources for physically unclonable function (PUF) data. PUF data may be acquired from the PUF sources. The resulting PUF values may be used to generate information that may be used for device security operations such as encryption and tamper detection.
Patent EP-3658798-A1 (EP)
Title: Method for making a brake disc and brake disc for disc brake
Inventor: CARMINATI FABIANO
IPC: C23C28/04
Filed: 2018-07-24
Abstract: The present invention relates to a method for making a brake disc, comprising the following operating steps: a) providing a disc brake comprising a braking band and provided with two opposite braking surfaces, made of aluminum or aluminum alloy or cast iron or steel; b) depositing on the disc a layer of chromium carbide (Cr3C2) and nickel-chromium (NiCr) in particle form, whereby forming a base protective coating (30) which covers at least one of the two braking surfaces of the braking band in direct contact therewith; and c) depositing on said base protective coating (30) a material in particle form consisting of tungsten carbide (WC), iron (Fe), chromium (Cr) and aluminum (Al), whereby forming a surface protective coating (3), consisting of tungsten carbide (WC) and iron (Fe), chromium (Cr) and aluminum (Al) and covering at least one of the two braking surfaces of the braking band. Both protective coatings are made by means of the HVOF (High Velocity Oxygen Fuel) or HVAF (High Velocity Air Fuel) or KM (Kinetic Metallization) techniques.
Patent EP-3661533-A1 (EP)
Title: A composition for use in the prevention and/or treatment of gastric or gastroesophageal diseases
Inventor: DI MAIO UMBERTO
IPC: A61K36/00
Filed: 2018-08-03
Abstract: The invention relates to a synergistic composition of naturally occurring substances, which is particularly effective in the treatment and prevention of gastric or gastroesophageal diseases. The composition of the invention comprises the synergistic combination of at least one antacid, an extract from a fruit of a plant of the genus  Musa , and at least one protease digestive enzyme. The synergistic composition of the present invention may be provided in the form of a pharmaceutical composition or a food supplement, or in the form of a kit-of-parts.
Patent EP-3593466-A1 (EP)
Inventor: POORREZAEI KAMAL
IPC: H04B7/212
Filed: 2018-03-06
Abstract: A wireless mesh network includes a mesh of continuously-powered devices (CPDs) and a mesh of battery-powered devices (BPDs). The BPDs are organized into hop layers based on hopping distance to the mesh of CPDs. In a medium latency communication mode, a given BPD receives data during a receive window that is scheduled to occur within either the first half of a communication window or the second half of the communication window, depending on the parity of the hop layer where the BPD resides. With this approach, a data packet can traverse one hop of the BPD mesh per communication window. In a low-latency communication mode, a given BPD receives and transmits data according to an alternating pattern that depends on the parity of the hop layer where the node resides. With this technique, a data packet can traverse multiple hops of the BPD mesh within a single communication window. These techniques also are applicable to CPDs and other types of nodes as well.
Patent EP-3597773-A1 (EP)
Inventor: SHIN YONG
IPC: C12N15/10
Filed: 2018-03-14
Abstract: The present invention relates to a method of concentrating microorganisms and a method of extracting nucleic acids using diatomaceous earth and developed a technology capable of concentrating microorganisms about 4-8 times using the modified diatomaceous earth and directly extracting nucleic acids from the concentrated microorganism using dimethyl adipimidate (DMA). It is expected to significantly reduce external contamination, cost, time and complexity by enabling microbial concentration and nucleic acid extraction techniques in one tube.
Patent EP-3692127-A1 (EP)
Inventor: HÄTZELT ANDRÉ
IPC: C07D498/04
Filed: 2018-09-25
Abstract: A compound based on 1-Aza-3,7-dioxabicyclo[3.3.0]octane (bicyclic oxazolidine derivative) substituted with 3-(4-isobutyl-2-methylphenyl)propyl, method for their preparation, and their use as pro-fragrances.
Patent EP-3610859-A1 (EP)
Inventor: MA QIAN
IPC: A61K9/127
Filed: 2018-04-12
Abstract: A cerasome delivery system for use in the targeted activation of a CD44 molecule, a preparation method and use thereof: a surface of a cerasome is partially modified by a targeting ligand, the targeting ligand being a ligand which may specifically bind to an activated CD44 molecule. The cerasome delivery system may be used for the diagnosis, prevention and treatment of vulnerable plaque or diseases associated with vulnerable plaque.
Patent EP-3700535-A1 (EP)
Inventor: SZEPETOWSKI PIERRE
IPC: A61P31/22
Filed: 2018-10-22
Abstract: The present invention relates the field of CMV and CMV related diseases. Using a powerful rat model of CMV infection of the embryonic brain, the inventors have looked for the existence of postnatal neurological and neurosensory manifestations, and have tested whether the early pharmacological targeting of microglia during pregnancy impacts on postnatal phenotypes. Particularly, the inventors tested the clodronate and the doxycycline and showed that these compounds improve the postnatal outcome of the baby. Thus, the invention relates to a compound which modifies the microglia for use in the treatment of CMV related diseases in a subject in need thereof.
Patent EP-3703645-A1 (EP)
Title: Medication reminder method, non-transitory readable storage medium storing said method, and medication reminder device
Inventor: HAN LITONG
IPC: A61J7/04
Filed: 2018-03-14
Abstract: A method, system, and non-transitory computer-readable storage medium storing a method for reminding a patient to comply with medication schedule. The method includes obtaining a measurement of at least one patient parameter; determining whether the measurement is outside of a range; when the measurement is outside of the range, determining a total time lapse since the previous administration of a dose of the medication; determining a concentration of the medication in blood of the patient based at least on the total time lapse; and when the concentration of the medication in the blood of the patient is below a threshold, generating a reminder to the patient to administer the next dose of the medication.
Patent EP-3618724-A1 (EP)
Inventor: MARKOWITZ SANFORD
IPC: A61B17/32
Filed: 2018-05-03
Abstract: A device for collecting a biological sample in an esophagus of a patient includes a swallowable collection portion for collecting a sample at a collection site in the esophagus. A stylet is connected with the collection portion for placing the collection portion into the back of a throat of a patient for swallowing. The device may have a collection portion having a first axial end portion and a second axial end portion. A sleeve is in the first axial end portion. The device may have at least one tissue collecting projection extending from an outer surface of the collection portion; a first side wall of the tissue collecting; a second wall of the tissue collecting projection. A method for collecting a biological sample includes moving the swallowable collection portion with the stylet into the back of a throat of a patient for swallowing.
Patent EP-3609107-A1 (EP)
Inventor: PENG JINLIN
IPC: H04L1/18
Filed: 2018-05-07
Abstract: This application relates to the field of wireless communications technologies, and in particular, to a data transmission method, an apparatus, and a system. random access resource information: receiving, by user equipment UE, data from a first access network device to which a serving cell belongs; sending, by the UE, a decoding result of the data to the first access network device and a second access network device to which a coordinating cell belongs; and if the decoding result is negative acknowledgment NACK signaling, receiving, by the UE from the first access network device, the data that is retransmitted, and receiving, by the UE, the data from the second access network device. This application is intended to flexibly assist, by using the second access network device, the first access network device in transmitting or retransmitting the data to the UE, to improve reliability of data transmission in a low latency scenario.
Patent EP-3707483-A1 (EP)
Title: Indicating the intensity of a predetermined type of radiation
Inventor: LASTUSAARI MIKA
IPC: C09K9/00
Filed: 2018-10-17
Abstract: The application relates to a detecting device (1) for indicating the intensity of a predetermined type of radiation present in electromagnetic radiation incident on the detecting device, wherein the detecting device comprises: a filter element (2) for filtering the incident electromagnetic radiation, wherein the filter element is configured to filter off electromagnetic radiation with a wavelength of above 590 nm from the incident electromagnetic radiation; a converging element (3) configured to increase the density of photons of the predetermined type of radiation present in the incident electromagnetic radiation; and - a sensor element of material (4) arranged to receive the incident electromagnetic radiation that has passed through the filter element and the converging element for indicating the intensity of the predetermined type of radiation present in the incident electromagnetic radiation by change of the color of the sensor element of material, wherein the material is represented by the following formula (I).
Patent EP-3704401-A1 (EP)
Inventor: ANCIAN MATHIEU
IPC: F16J15/06
Filed: 2018-10-08
Abstract: A seal (10) comprises at least one portion made of a deformable material having a sealing function, and at least one sensor (2) which is incorporated in the seal, being stuck to the deformable material having a sealing function. For an adhesion effect between the sensor and the deformable material, a stack comprising a film of adhesion primer (6, 8) in contact with the surface of the sensor, a portion of fabric (4, 5) impregnated with an elastomer, and another film of adhesion primer (7, 9) for contact with the deformable material is provided. Cohesion of the seal and resistance to delamination are provided by the adhesion between the sensor (2) and the deformable material having a sealing function. The sensor may be a pressure sensor and the seal may be intended for a valve of a hydroelectric plant.
Patent EP-3565727-A1 (EP)
Inventor: KALKBRENNER GABRIEL
IPC: B60J7/057
Filed: 2018-10-23
Abstract: The invention relates to a frame of a vehicle roof, comprising a cable-guide element in which a cable channel (42, 72), for receiving a drive cable (38A, 38B) for an adjustable roof element, is formed and delimited by a channel wall. Said channel wall comprises an uncoiling cutout which is longer in the longitudinal direction of the cable channel (42) than a limiting uncoiling length.
Patent EP-3849334-A1 (EP)
Inventor: BADRI DAYAKAR
IPC: A23K10/26
Filed: 2018-10-18
Abstract: Described herein are pet food compositions for enhancing nicotinamide adenine dinucleotide metabolism and increasing levels of nicotinamide adenine dinucleotide oxidized form, the food composition including a protein, a carbohydrate, and a dietary fiber that includes insoluble fiber and soluble fiber in a weight ratio ranging from about 8:1 to about 14:1, whereby the dietary fiber is present in an amount ranging from about 2 wt. % to about 10 wt. % based on the total weight of the food composition.
Patent EP-3630154-A1 (EP)
Title: Lipo-glycopeptide cleavable derivatives and uses thereof
Inventor: HECKLER RYAN
IPC: C07K7/64
Filed: 2018-05-22
Abstract: The present invention provides certain lipo-glycopeptide cleavable derivatives and methods for using the same for the treatment of bacterial infections, for example, pulmonary bacterial infections. The LGPC derivatives include a cleavable moiety that in certain embodiments, is designed to allow for cellular uptake and/or a more rapid clearance of the glycopeptide metabolite (i.e., the cleaved glycopeptide) from the site of administration (e.g., the lung) as compared to the uncleaved LGPC.
Patent EP-3713460-A1 (EP)
Inventor: MORIN GILLES
IPC: A47J31/40
Filed: 2018-11-05
Abstract: The invention concerns a coffee machine (1) comprising an infusion zone (7), a reservoir (5) for storing ground coffee arranged above the infusion zone (7) and a device for transferring coffee grounds from the storage reservoir (5) to the infusion zone through an opening (14), as well as a control system (40) comprising at least one member (41) for selecting a quantity of coffee grounds to be dispensed, said device for transferring coffee grounds comprising a dispensing member (9) rotated by a motor (12). According to the invention, the device for transferring coffee grounds comprises a member (17) for manipulating a device (16) for opening and closing the opening (14), which can move between an open position and a closed position, the manipulating member (17) being able to move between an activated position, in which the opening and closing device (16) is in the open position, and a rest position in which the opening and closing device (16) is in the closed position, and the control system (40) comprises a detection member (32) for detecting the open position of the opening and closing device (16) and a means (42) for cutting the power to the motor (12) which cuts the power to the motor (12) after the dispensing of the quantity of coffee grounds to be dispensed, the detecting member (32) always detecting the open position.
Patent EP-3725109-A1 (EP)
Inventor: BOGUSZ FRANÇOIS
IPC: H04W12/08
Filed: 2018-12-04
Abstract: The invention is a method for managing a tamper-proof device (30) comprising first and second software containers (32, 34),said tamper-proof device (30) being included in a host device (80) comprising a baseband unit (10). Said first software container (32) is designed to emulate a eUICC and is in a deactivated state. The second software container comprises a set (36) of rules. The baseband unit comprises an activator agent (12)which retrieves both a location data broadcasted by a telecom network and the set of rules from the second software container. The activator agent checks if activation of the first software container is authorized by one of said rules for the location data and requests activation of the first software container only in case of successful checking.
Patent EP-3637348-A1 (EP)
Inventor: LOPEZ GALARZA EDGAR HERNANDO
IPC: G06Q30/00
Filed: 2018-03-22
Abstract: The present invention refers to a system for detecting mount events in animals, which uses the technique of intrabody (IBC) signal transmission. The system is comprised by a fundamental unir disponsed in each animal, which comprises an electronic box (13) fastened to the neck of each animal through a collar (12) and mainly formed by four modules: 1) processor, 2) sensor; 3) IBC (Intra-Body Communication) transceiver, 4) RF (radiofrequency) transceiver. The process for detecting the mount event with the system disclosed herein is also provided.
Patent EP-3728297-A1 (EP)
Title: Ancestral cellulases and uses thereof
Inventor: PÉREZ-JIMÉNEZ RAÚL
IPC: C07K14/36
Filed: 2018-12-18
Abstract: The invention relates to a polypeptide comprising an exoglucanase catalytic domain comprising a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3,and to a polypeptide having beta-glucosidase activity comprising a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8, and to functionally equivalent variants thereof that maintain or improve their catalytic activity. Additionally, the invention relates to an enzyme cocktail comprising said polypeptide(s) and an endoglucanase. Further, the invention also relates to methods for hydrolysing cellulose to cellobiose and/or cellotetraose, cellobiose and/or cellotetraose to glucose and cellulose to glucose, and to produce bioethanol, using the polypeptides or enzyme cocktails of the invention, and to the uses of the polypeptides and enzyme cocktails of the invention for hydrolysing cellulose to cellobiose and/or cellotetraose, cellobiose and/or cellotetraose to glucose and cellulose to glucose, and to produce bioethanol.
Patent EP-3641515-A1 (EP)
Inventor: UKEI HIROICHI
IPC: H05K9/00
Filed: 2018-01-23
Abstract: An electromagnetic wave absorber (1a) includes a first layer (10) and an electrically conductive layer (20). The first layer (10) is a dielectric layer or a magnetic layer. The electrically conductive layer (20) is provided on at least one surface of the first layer. A product of a Young's modulus of the first layer (10) and a thickness of the first layer (10) is 0.1 to 1000 MPa•mm. The first layer (10) has a relative permittivity of 1 to 10.
Patent EP-3711210-A1 (EP)
Title: Methods and apparatus for reporting aperiodic cqi in a new scell state of lte carrier aggregation
Inventor: KADIRI PRASAD
IPC: H04L1/00
Filed: 2018-11-15
Abstract: Certain aspects of the present disclosure relate to methods and apparatus for reporting aperiodic channel quality indicator (A-CQI) in a new Secondary Cell (SCell) state of Long Term Evolution (LTE) carrier aggregation. A User Equipment (UE) receives a request for reporting A-CQI relating to a Scell configured for the UE when the UE is in a first state corresponding to the Scell, the first state designed for a reduced SCell activation latency and to result in the UE using lower power as compared to when the UE is in a second state. The UE, in response to the request, reports the A-CQI for the Scell in accordance with a first A-CQI reporting configuration for the first state which is different from a second A-CQI reporting configuration for the second state.
Patent EP-3643726-A1 (EP)
Inventor: TING HONG HOI
IPC: C12N15/13
Filed: 2018-06-20
Abstract: Provided are an anti-Her2 nanobody and a coding sequence and the use thereof. In particular, provided is a nanobody combating human epidermal growth factor receptor-2 (Her2/ERBB2). Disclosed are the nanobody and the a gene sequence encoding the nanobody, a corresponding expression vector and a host cell capable of expressing the nanobody, and a method for producing the nanobody of the present invention and the related use thereof. The present invention may also provide an immunoconjugate of the nanobody and the use thereof, especially the use in the diagnosis and treatment of Her2 positive tumor.
Patent EP-3728127-A1 (EP)
Inventor: ROBERTS MATTHEW
IPC: C01G53/00
Filed: 2018-12-18
Abstract: A compound of the general formula: wherein x is equal to or greater than 0.175 and equal to or less than 0.325 and y is equal to or greater than 0.05 and equal to or less than 0.35. In another embodiment, x is equal to zero and y is greater than 0.12 and equal to or less than 0.4. The compound is also formulated into a positive electrode for use in an electrochemical cell.
Patent EP-3716874-A1 (EP)
Inventor: SCHULTHEIS ERIC A
IPC: A61B18/02
Filed: 2018-11-30
Abstract: A fluid injection line compensation assembly for an intravascular catheter system including a balloon catheter having a guidewire lumen and a cryoballoon, includes a fluid injection line, a proximal fluid injection line stop, and a distal fluid injection line stop. The fluid injection line has a fluid discharge region positioned within the cryoballoon. The fluid discharge region includes a fluid port so that cryogenic fluid can be distributed from the fluid injection line to within the cryoballoon. The fluid discharge region is not affixed to the guidewire lumen. The proximal fluid injection line stop is positioned adjacent to the guidewire lumen, the proximal fluid injection line stop being positioned within the cryoballoon. The distal fluid injection line stop is positioned adjacent to the guidewire lumen so that the fluid discharge region is positioned between the proximal fluid injection line stop and the distal fluid injection line stop.
Patent EP-3732539-A1 (EP)
Inventor: MARTYNENKO SERGEY
IPC: G05B19/418
Filed: 2018-12-20
Abstract: In a method for machining workpieces (12), a starting workpiece (12) is machined using a tool (60, 62) of a machine tool (10) and a value of a quality feature resulting from the machining process is determined on the machined workpiece (14). According to the invention, a value of a variable characterising a status of the tool (60, 62) is determined during the machining process and/or before and/or after the machining process, and a dataset is created and stored in a memory (52), which links at least the value of the quality feature and the value of the variable characterising the status of the tool (60, 62) to one another.
Patent EP-3775596-A1 (EP)
Inventor: SILVESTRINI RICHARD LARRY
IPC: F16D129/08
Filed: 2018-11-19
Abstract: An electromagnetic brake is provided in which short duration current pulses move the brake between engaged and disengaged states. A first current pulse having a first polarity is delivered to a conductor within a field shell when the brake is engaged and establishes an electromagnetic circuit including the field shell and an armature plate that urges the armature plate away from a rotating friction plate and towards the field shell to disengage the brake. A magnetic circuit is maintained after termination of the first current pulse due to a remanence in at least one of the armature plate and the field shell. A second current pulse having a second polarity opposite the first polarity delivered to the conductor when the brake is disengaged weakens the magnetic circuit thereby allowing a spring to move the armature plate away from the field shell and towards the friction plate to engage the brake.